Search

everythinglearnresearchcommunity

for

Search:↓

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Dupilumab helps children with alopecia areata regrow hair safely.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.